carmustine has been researched along with 3,4-dihydroxybenzohydroxamic acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Bauer, W; Elford, HL; Fritzer-Szekeres, M; Höchtl, T; Horvath, Z; Szekeres, T; Tihan, T | 1 |
| Bauer, W; Fritzer-Szekeres, M; Hoechtl, T; Horvath, Z; Saiko, P; Szekeres, T; Tihan, T | 1 |
3 other study(ies) available for carmustine and 3,4-dihydroxybenzohydroxamic acid
| Article | Year |
|---|---|
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Synergistic cytotoxicity of the ribonucleotide reductase inhibitor didox (3,4-dihydroxy-benzohydroxamic acid) and the alkylating agent carmustine (BCNU) in 9L rat gliosarcoma cells and DAOY human medulloblastoma cells.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Brain Neoplasms; Carmustine; Cerebellar Neoplasms; Drug Interactions; Gliosarcoma; Humans; Hydroxamic Acids; Medulloblastoma; Rats; Tumor Cells, Cultured | 2004 |
Combination chemotherapy of BCNU and Didox acts synergystically in 9L glioma cells.
Topics: Animals; Anti-Infective Agents, Local; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Cell Line, Tumor; Chromatography, High Pressure Liquid; Coloring Agents; DNA Repair; DNA, Complementary; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gene Expression Regulation; Gentian Violet; Glioblastoma; Glioma; Hydroxamic Acids; Oligonucleotide Array Sequence Analysis; Rats; Time Factors | 2004 |